Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor

Artificial Organs

Volumn 33, Issue 3, 2009, Pages 230-239

  Zhou, Min ^a   Liu, Zhao ^a   Wei, Zhiqing ^a   Liu, Changjian ^a   Qiao, Tong ^a   Ran, Feng ^a   Bai, Yan ^a   Jiang, Xuefeng ^b   Ding, Ying ^c  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Decellularization; Heparin; Neointimal hyperplasia; Vascular endothelial growth factor; Vascular graft

Indexed keywords

BIOACTIVITY; CELL ENGINEERING; COATINGS; CYTOLOGY; ENDOTHELIAL CELLS; SCAFFOLDS (BIOLOGY);

'CURRENT; DECELLULARIZATION; DECELLULARIZED; GRAFT-FROM; HEPARIN IMMOBILIZATION; NEOINTIMAL HYPERPLASIA; SMALL DIAMETER VASCULAR PROSTHESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR GRAFTS; VASCULAR TISSUE;

POLYSACCHARIDES;

HEPARIN; VASCULOTROPIN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; DOG; EXTRACELLULAR SPACE; FEMALE; GRAFT PATENCY; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURFACE PROPERTY; THROMBOSIS; TISSUE ENGINEERING; TISSUE PREPARATION;

EID: 61349109316     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00713.x     Document Type: Article

References (29)

1. Whittermore AD, Kent KC, Donaldson MC, Couch NP, Mannick JA. What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction? J Vasc Surg 1989 10 : 299 305.
2. Kakisis JD, Liapis CD, Breuer C, Sumpio BE. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J Vasc Surg 2005 41 : 349 54.
3. Roy S, Silacci P, Stergiopulos N. Biomechanical properties of decellularized porcine common carotid arteries. Am J Physiol Heart Circ Physiol 2005 289 : H1567 76.
4. Takagi K, Fukunaga S, Nishi A, et al. In vivo recellularization of plain decellularized xenografts with specific cell characterization in the systemic circulation: histological and immunohistochemical study. Artif Organs 2006 30 : 233 41.
5. Conklin BS, Richter ER, Kreutziger KL, Zhong DS, Chen C. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 2002 24 : 173 83.
6. Wang XN, Chen CZ, Yang M, Gu YJ. Implantation of decellularized small-caliber vascular xenografts with and without surface heparin treatment. Artif Organs 2007 31 : 99 104.
7. Teebken OE, Bader A, Steinhoff G, Haverich A. Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg 2000 19 : 381 6.
8. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001 7 : 1035 40.
9. Cho SW, Lim SH, Kim IK, et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 2005 241 : 506 15.
10. Conklin BS, Wu H, Lin PH, Lumsden AB, Chen C. Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft. Artif Organs 2004 28 : 668 75.
11. Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003 9 : 669 76.
12. Asahara T, Bauters C, Pastore C, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon injured rat carotid artery. Circulation 1995 91 : 2793 801.
13. Van Belle E, Tio FO, Couffinhal T, Maillard L, Passeri J, Isner JM. Stent endothelialization: time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 1997 95 : 438 48.
14. Luo Z, Asahara T, Tsurumi Y, Isner JM, Symes JF. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. J Vasc Surg 1998 27 : 167 73.
15. Hutter R, Carrick FE, Valdiviezo C, et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 2004 110 : 2430 5.
16. Yao C, Roderfeld M, Rath T, Roeb E, Bernhagen J, Steffens G. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. Biomaterials 2006 27 : 1608 16.
17. Sporn LA, Bunce LA, Francis CW. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood 1995 86 : 1802 10.
18. Randone B, Cavallaro G, Polistena A, et al. Dual role of VEGF in pretreated experimental ePTFE arterial grafts. J Surg Res 2005 127 : 70 9.
19. Allaire E, Bruneval P, Mandet C, Becquemin JP, Michel JB. The immunogenicity of the extracellular matrix in arterial xenografts. Surgery 1997 122 : 73 81.
20. Madden RL, Lipkowitz GS, Browne BJ, Kurbanov A. Experience with cryopreserved cadaveric femoral vein allografts used for hemodialysis access. Ann Vasc Surg 2004 18 : 453 8.
21. Noishiki Y, Miyata T. Successful animal study of small caliber heparin-protamine-collagen vascular grafts. ASAIO Trans 1985 31 : 102 6.
22. Wissink MJ, Beernink R, Pieper JS, et al. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials 2001 22 : 151 63.
23. Pike DB, Cai S, Pomraning KR, et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006 27 : 5242 51.
24. Robinson CJ, Mulloy B, Gallagher JT, Stringer SE. VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J Biol Chem 2006 281 : 1731 40.
25. Gengrinovitch S, Berman B, David G, Witte L, Neufeld G, Ron D. Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J Biol Chem 1999 274 : 10816 22.
26. Dorafshar AH, Angle N, Bryer-Ash M, et al. Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation. J Surg Res 2003 114 : 179 86.
27. Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle cell-proliferation in injured arteries. Nature 1977 265 : 625 6.
28. Hoover RL, Rosenberg R, Haering W, Karnovsky MJ. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ Res 1980 47 : 578 83.
29. Walpoth BH, Zammaretti P, Cikirikcioglu M, et al. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. J Thorac Cardiovasc Surg 2007 133 : 1163 70.